Phena-Lean
100/100
This product looks safe
- No ingredients exceed tolerable upper intake levels
- 50% of ingredients have research evidence
A
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Label Data
1 Capsule(s)
Serving Size
60
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Supplement Facts — Evidence Check
25 mg
(156% DV)
✅ 1.8× RDA — within safe limits
📚 193 studies (Tier A: 5, B: 63)
Phena-Lean Blend
766 mg
Other Ingredients
Gelatin
Silicon Dioxide
Magnesium Stearate
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Product Information
📋 Directions for Use
Suggested use Take 1 capsule daily with 8-12 fl. oz. of water.
⚠️ Warnings & Precautions
Warnings Do not exceed recommended dosage. This product contains caffeine and should not be used with any other caffeine containing products.
Not intended for anyone under the age of 18. Keep out of reach of children.
If you are nursing, pregnant, taking medication or have a medical condition, consult your physician before taking this product.
Manufactured in a facility which processes milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame.
Contains 250mg of total caffeine.
Additional Information
Keep in a cool, dry & dark place.
Facebook facebook.com/anabolicwarfare Instagram @anabolicwarfare
cGMP
Product Details
UPC / SKU
8 12575 03186 6
DSLD Entry Date
2024-06-20
Product Type
Other Combinations
Form
Capsule
Brand
Anabolic Warfare
DSLD ID
307030
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Serotone 5HTP 50 mg
Higher Nature
100
Serotone 5HTP 100 mg
Higher Nature
100
ChromeMate
NOW
100
ChromeMate 200 mcg
Protocol For Life Balance
100
Non Flush Niacin
Highland Laboratories
100